is bupropion a glp 1 drug Current Strategies in Managing Obesity Obesity drugs under review: Semaglutide,
Description
Unlike opioid-based treatments, they do not carry risks of dependency
10.1016/S0140-6736(21)00213-0
Discussion PCOS is a prevalent, highly heterogeneous condition affecting women of reproductive age, frequently involving metabolic comorbidities
Tirzepatide is the only licenced GLP-1/GIP co-agonist for obesity, with several more GLP-1/GIP co-agonists in development [15]
Hormonal fluctuations may also play a role, though this mechanism is not firmly established in GLP-1 users
doi: 10.1093/ndt/gfaa380
